Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
RESEARCH TOOLSreports
Holding BRNS?
Track your performance easily
Barinthus Biotherapeutics (BRNS) Ownership Overview
3.65%
Insiders
0.03% Mutual Funds
24.29% Other Institutional Investors
72.02% Public Companies and
Individual Investors
The ownership structure of Barinthus Biotherapeutics (BRNS) stock is a mix of institutional, retail, and individual investors. , 3.65% is owned by Insiders, and 72.02% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,243,377 | Insider | 3.19% | 1,228,456 | |
| 104,209 | Insider | 0.27% | 102,958 | |
| 48,256 | Insider | 0.12% | 47,677 | |
| 23,000 | Insider | 0.06% | 22,724 | |
| 11,568 | Institution | 0.03% | 11,429 | |
| 3,000 | Insider | <0.01% | 2,964 | |
| 3,000 | Insider | <0.01% | 2,964 | |
| 1,700 | Insider | <0.01% | 1,680 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,568 | Institution | 0.03% | 11,429 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Barinthus Biotherapeutics (BRNS)?
According to the latest TipRanks data, approximately 24.29% of the company's stock is held by institutional investors, 3.65% is held by insiders, and 72.02% is held by retail investors.
What percentage of Barinthus Biotherapeutics (BRNS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 24.29% of Barinthus Biotherapeutics (BRNS) stock is held by institutional investors.
What percentage of Barinthus Biotherapeutics (BRNS) stock is held by retail investors?
According to the latest TipRanks data, approximately 72.02% of Barinthus Biotherapeutics (BRNS) stock is held by retail investors.
Who owns the most shares of Barinthus Biotherapeutics (BRNS)?
William Enright owns the most shares of Barinthus Biotherapeutics (BRNS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.